Navigation Links
Pharmalink Regulatory Affairs Consulting Firm Opens New Offices in Washington, DC and Hartford, CT
Date:2/1/2010

Pharmalink Consulting, the leading provider of quality regulatory affairs resource to the healthcare industry (http://www.pharmalinkconsulting.com), has opened new offices in Washington, DC and Hartford, CT, strengthening and improving access to its expanding team of regulatory affairs consultants and contractors. This is the latest step in Pharmalink’s expansion of its global regulatory affairs consulting services throughout the United States.

(PRWEB) February 1, 2010 -- Pharmalink Consulting, the leading provider of quality regulatory affairs resource to the healthcare industry (http://www.pharmalinkconsulting.com), has opened new offices in Washington, DC and Hartford, CT, strengthening and improving access to its expanding team of regulatory affairs consultants and contractors. This is the latest step in Pharmalink’s expansion of its global regulatory affairs consulting services throughout the United States.

"The opening of these additional offices in Connecticut and DC reaffirms Pharmalink’s commitment to both new and existing clients on the East Coast — an area of key strategic focus for us. It will enable us to provide them with the strengths of a global regulatory affairs consultancy, combined with local market expertise," said CEO of Pharmalink Consulting’s North American operations Stephen Loughrey.

With the expansion Pharmalink has also announced the following new hires reporting to Mr. Loughrey:

 
  • Jamie Sulley as General Manager with responsibility for MA and CT.
  • Dave Yungvirt as Head of Resourcing and Contracts for Pharmalink Consulting, Inc.

Mr. Loughrey said: "We are pleased to welcome Jamie and Dave to Pharmalink Consulting, and are looking forward to working together in growing and strengthening our presence in this important market."

About Pharmalink Consulting:

Pharmalink Consulting is one of the world's leading independent Regulatory Affairs specialists. With offices in the US; Europe and Asia Pacific, Pharmalink serves the global healthcare industry with diverse clients from the Pharmaceutical, Biotech, Medical Device and Consumer Health sectors. For more information on Pharmalink Consulting, please visit Pharmalink Consulting.

Contacts

For Pharmalink Consulting Inc – Worldwide Regulatory Affairs
Stephen Loughrey
Chief Executive Officer
Direct Tel: (973) 218-2725
Fax: (973) 218-2726
Main Tel: (1) 800-434-5808

US LOCATIONS: Short Hills, NJ; Cambridge, MA; King Of Prussia, PA; Durham, NC; Midtown Manhattan, NY; San Francisco, CA; Hartford, CT; Washington, DC.

INTERNATIONAL OFFICES: Maidenhead, UK; Mumbai, India.

###

Read the full story at http://www.prweb.com/releases/pharmalink-consulting/regulatory-afffairs/prweb3534594.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
3. Biomoda, Inc. and Quintiles Announce Agreement for Regulatory Consulting
4. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
5. UCSD study reveals the regulatory mechanism of key enzyme
6. UCSD study reveals the regulatory mechanism of key enzyme
7. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
8. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
9. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
10. Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
11. Ground Zero Pharmaceuticals Announces Expansion of Regulatory Consulting Services to South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: